Turning Point Therapeutics: 3Q Earnings Snapshot

November 4, 2019 GMT

SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Monday reported a loss of $20.5 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 63 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TPTX at https://www.zacks.com/ap/TPTX